ARXS — Arxis, Inc. Class A Common Stock stock price, charts and financials
QT57Arxis, Inc. Class A Common StockArxis, Inc. Class A Common Stock (NASDAQ: ARXS) is a Industrials company in the Aerospace & Defense industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | - | EPS (ttm) | 0.12 | Insider Own | - | Shs Outstand | 40.50M | Perf Week | -0.82% |
| Market Cap | 2.11B | Forward P/E | 56.72 | EPS next Y | 0.92 | Insider Trans | - | Shs Float | - | Perf Month | -6.62% |
| Enterprise Value | 3.49B | PEG | 13.47 | EPS next Q | - | Inst Own | - | Short Float | 7.22% | Perf Quarter | 19.28% |
| Income | -50.00M | P/S | 1.32 | EPS this Y | 295.70% | Inst Trans | - | Short Ratio | 3.15 | Perf Half Y | - |
| Sales | 1.60B | P/B | 0.50 | EPS next Y | 93.15% | ROA | 0.69% | Short Interest | 2.92M | Perf YTD | 36.89% |
| Book/sh | 103.73 | P/C | 3.76 | EPS next 5Y | 32.19% | ROE | 1.27% | 52W High | 61.50 -15.41% | Perf Year | - |
| Cash/sh | 13.85 | P/FCF | 13.97 | EPS past 3/5Y | - | ROIC | 1.51% | 52W Low | 33.15 56.92% | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | 11.13 | Sales past 3/5Y | - | Gross Margin | 51.84% | Volatility | 5.73% 4.38% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 2.18 | EPS Y/Y TTM | - | Oper. Margin | 14.92% | ATR (14) | 2.52 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.79 | Sales Y/Y TTM | - | Profit Margin | 5.04% | RSI (14) | 50.85 | Recom | 2.13 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.21 | EPS Q/Q | -107.69% | SMA20 | -0.04% | Beta | 1.97 | Target Price | 50.67 |
| Payout | 0.69% | Debt/Eq | 0.46 | Sales Q/Q | - | SMA50 | 2.43% | Rel Volume | 3.79 | Prev Close | 49.70 |
| Employees | 5,753 | LT Debt/Eq | 0.46 | Earnings | Jul 29 | SMA200 | 16.18% | Avg Volume | 886.61K | Price | 52.02 |
| IPO Date | Apr 16, 2026 | Option/Short | No / Yes | EPS/Sales Surpr. | 88.03% 5.50% | Net Debt/EBITDA | 5.06 | Volume | 3,359,915 | Change | 4.67% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-03-26 | Reiterated | Morgan Stanley | Overweight | $50 → $62 |
| Aug-02-26 | Reiterated | Jefferies | $55 → $60 | |
| Jun-01-26 | Reiterated | Wells Fargo | Overweight | $42 → $52 |
| Jun-01-26 | Reiterated | Morgan Stanley | Overweight | $44 → $50 |
| May-31-26 | Reiterated | Jefferies | $42 → $55 | |
| May-29-26 | Reiterated | RBC Capital | Sector Perform | $39 → $46 |
| May-11-26 | Initiated | Melius Research | Buy | $45 |
| May-11-26 | Initiated | Wells Fargo | Overweight | $42 |
| May-11-26 | Initiated | Jefferies | Buy | $42 |
| May-11-26 | Initiated | Wolfe Research | Outperform | $43 |
Arxis, Inc. specializes in the creation and production of electronic and mechanical components that are crucial for highly sensitive operations, primarily serving clients within the United States. Its expertise lies in delivering meticulously engineered parts designed to function reliably in demanding, high-performance, and extreme conditions. These include a range of specialized items such as connectors, cable assemblies, radio frequency (RF) and microwave components, various sensors, precision bearings, and intricate mechanical parts. Furthermore, the company's offerings are integral to a diverse array of advanced systems, spanning aerospace, defense, space exploration, medical technology, semiconductor testing, industrial automation, and highly specialized industrial applications. Arxis serves a broad clientele, encompassing defense and space initiatives, commercial aviation, medical device manufacturers, semiconductor testing facilities, and various industrial technology sectors that demand robust, purpose-built components for challenging operational scenarios. Established in 2019, Arxis operates from its headquarters situated in Bloomfield, Connecticut.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | FY 2025 12/31/2025 | |
|---|---|---|
| Total Revenue | 1,601 | |
| Cost of Goods Sold Incl. D&A | 843 | |
| Gross Profit | 758 | |
| Selling, General and Administrative Excl. Other | 510 | |
| Research and Development | 0 | |
| Other Operating Expense | 140 | |
| Operating Income | 108 | |
| Interest Expense | 179 | |
| Unusual Expense | — | |
| Non-Operating Income (Expense) | 6 | |
| Net Income Before Taxes | -65 | |
| Income Taxes | -15 | |
| Consolidated Net Income | -50 | |
| Net Income From Continuing Operations | -50 | |
| Net Income | -50 | |
| EPS (Recurring) | -0.12 | |
| EPS (Basic, Before Extraordinaries) | -0.12 | |
| EPS (Diluted) | -0.12 | |
| EBITDA | 314 | |
| Other After Tax Adjustments | — | |
| Stock Option Compensation Expense | — | |
| Price To Earnings Ratio | — | |
| Price To Sales Ratio | — | |
| Gross Margin | 47.35 | |
| Operating Margin | 6.75 | |
| Net Margin | -3.12 | |
| Shares Outstanding | 404 | |
| Market Capitalization | — | |
| Operating Lease Expense | — |